PI3K/Akt is a potent survival pathway that has been implicated in the acquired resistance to apoptotic cell death associated with treatment with chemotherapeutic drugs and radiation therapy in a variety of cancers including pancreatic cancer [22], [23]. Here, AKT1 is linked to familial pancreatic carcinoma.